Instil Bio Q2 Adj. EPS $(2.88) Misses $(2.50) Estimate, Cash, Cash Equivalents, Restricted Cash, Marketable Securities And Long-term Investments Of $103.6M Will Enable The Company To Fund Its Operating Plan Beyond 2026
Author: Benzinga Newsdesk | August 13, 2025 05:15am